ASPIRA PATHLAB & DIAGNOSTICS | AATMAJ HEALTHCARE LTD. | ASPIRA PATHLAB & DIAGNOSTICS / AATMAJ HEALTHCARE LTD. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -12.6 | - | - | View Chart |
P/BV | x | 2.4 | 6.0 | 40.0% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
ASPIRA PATHLAB & DIAGNOSTICS AATMAJ HEALTHCARE LTD. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ASPIRA PATHLAB & DIAGNOSTICS Mar-23 |
AATMAJ HEALTHCARE LTD. Mar-23 |
ASPIRA PATHLAB & DIAGNOSTICS / AATMAJ HEALTHCARE LTD. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 75 | NA | - | |
Low | Rs | 26 | NA | - | |
Sales per share (Unadj.) | Rs | 14.0 | 16.8 | 83.8% | |
Earnings per share (Unadj.) | Rs | -0.1 | 3.6 | -2.4% | |
Cash flow per share (Unadj.) | Rs | 1.5 | 4.1 | 35.7% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 12.4 | 8.8 | 141.6% | |
Shares outstanding (eoy) | m | 10.29 | 16.20 | 63.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.6 | 0 | - | |
Avg P/E ratio | x | -583.7 | 0 | - | |
P/CF ratio (eoy) | x | 34.6 | 0 | - | |
Price / Book Value ratio | x | 4.1 | 0 | - | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 518 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 56 | 47 | 120.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 145 | 272 | 53.2% | |
Other income | Rs m | 3 | 0 | 1,234.6% | |
Total revenues | Rs m | 148 | 272 | 54.4% | |
Gross profit | Rs m | 16 | 98 | 16.2% | |
Depreciation | Rs m | 16 | 7 | 230.5% | |
Interest | Rs m | 4 | 9 | 46.6% | |
Profit before tax | Rs m | -1 | 83 | -1.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 24 | 0.0% | |
Profit after tax | Rs m | -1 | 59 | -1.5% | |
Gross profit margin | % | 11.0 | 36.2 | 30.5% | |
Effective tax rate | % | 0 | 28.6 | -0.0% | |
Net profit margin | % | -0.6 | 21.7 | -2.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 59 | 198 | 29.5% | |
Current liabilities | Rs m | 16 | 144 | 11.0% | |
Net working cap to sales | % | 29.5 | 20.1 | 146.7% | |
Current ratio | x | 3.7 | 1.4 | 267.6% | |
Inventory Days | Days | 88 | 0 | - | |
Debtors Days | Days | 590 | 2,395 | 24.6% | |
Net fixed assets | Rs m | 115 | 112 | 102.8% | |
Share capital | Rs m | 103 | 81 | 127.1% | |
"Free" reserves | Rs m | 25 | 61 | 40.4% | |
Net worth | Rs m | 128 | 142 | 89.9% | |
Long term debt | Rs m | 10 | 18 | 53.7% | |
Total assets | Rs m | 173 | 310 | 55.9% | |
Interest coverage | x | 0.8 | 10.2 | 7.7% | |
Debt to equity ratio | x | 0.1 | 0.1 | 59.7% | |
Sales to assets ratio | x | 0.8 | 0.9 | 95.2% | |
Return on assets | % | 1.9 | 21.9 | 8.6% | |
Return on equity | % | -0.7 | 41.7 | -1.7% | |
Return on capital | % | 2.4 | 57.4 | 4.2% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 0 | 53 | -0.2% | |
From Investments | Rs m | 2 | -14 | -11.2% | |
From Financial Activity | Rs m | -9 | -38 | 24.8% | |
Net Cashflow | Rs m | -8 | 1 | -579.4% |
Indian Promoters | % | 18.7 | 63.7 | 29.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 81.3 | 36.3 | 224.0% | |
Shareholders | 1,512 | 1,537 | 98.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ASPIRA PATHLAB & DIAGNOSTICS With: APOLLO HOSPITALS DR. LAL PATHLABS METROPOLIS HEALTHCARE KIMS NARAYANA HRUDAYALAYA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ASPIRA PATHLAB & DIAGNOSTICS | AATMAJ HEALTHCARE LTD. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 4.98% | 1.21% | -0.08% |
1-Month | -1.20% | 3.44% | 0.53% |
1-Year | -11.42% | -26.78% | 50.88% |
3-Year CAGR | -1.76% | -9.87% | 13.33% |
5-Year CAGR | -4.03% | -6.04% | 21.12% |
* Compound Annual Growth Rate
Here are more details on the ASPIRA PATHLAB & DIAGNOSTICS share price and the AATMAJ HEALTHCARE LTD. share price.
Moving on to shareholding structures...
The promoters of ASPIRA PATHLAB & DIAGNOSTICS hold a 18.7% stake in the company. In case of AATMAJ HEALTHCARE LTD. the stake stands at 63.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASPIRA PATHLAB & DIAGNOSTICS and the shareholding pattern of AATMAJ HEALTHCARE LTD..
Finally, a word on dividends...
In the most recent financial year, ASPIRA PATHLAB & DIAGNOSTICS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
AATMAJ HEALTHCARE LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of ASPIRA PATHLAB & DIAGNOSTICS , and the dividend history of AATMAJ HEALTHCARE LTD..
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the day higher.